Wilsons Sticks to Its Hold Rating for Next Science Ltd (NXSCF)
In a report released on January 31, Shane Storey from Wilsons maintained a Hold rating on Next Science Ltd (NXSCF – Research Report), with...
Stay updated with breaking news from Shane Storey. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In a report released on January 31, Shane Storey from Wilsons maintained a Hold rating on Next Science Ltd (NXSCF – Research Report), with...
Wilsons analyst Shane Storey upgraded Next Science Ltd (NXSCF – Research Report) to a Buy today and set a price target of A$0.57. The comp...
Wilsons analyst Shane Storey maintained a Hold rating on Next Science Ltd (NXSCF – Research Report) on July 28 and set a price target of A...
Wilsons analyst Shane Storey maintained a Hold rating on Nanosonics Limited (NNCSF – Research Report) on April 21 and set a price target o...
Head of research and development Bill Mezzanotte said the cost of bringing a treatment like its Hemgenix to market exceeded $US1 billion ($1.49 billion)